Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
clinicaladvisor.com2d
Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease
The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular ...
STAT7d
Ozempic approved for chronic kidney disease patients
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
960 The Ref on MSN7d
FDA approves Ozempic to reduce risk of kidney disease progression, cardiovascular death
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...
The Financial Times3d
Ozempic has curbed the obesity crisis. Has it killed the joy of food?
“The type of food GLP-1 users want changes; their tastebuds change,” says New York-based physician Dr Alexandra Sowa, author of The Ozempic Revolution (HarperCollins, £25). “People crave ...
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
Novo’s newest GLP-1, CagriSema, is the first big test of Novo Nordisk’s future as the leader in the obesity treatment market.
New York Post8d
Skinny ‘Ozempic’ phones are making a comeback: ‘A nostalgic twist’
Its highly-anticipated iPhone model will be 2 millimeters thinner than existing models — a decrease of roughly 25%, per Bloomberg, which cheekily likened devices of the skinny phone trend to Ben ...